Charles River Laboratories International (CRL) Non-Current Deffered Revenue (2010 - 2011)
Charles River Laboratories International (CRL) recorded quarterly Non-Current Deffered Revenue of $25.4 million in Q3 2011, up 1.05% quarter-over-quarter from $25.2 million in Q2 2011.
Charles River Laboratories International (CRL) Non-Current Deffered Revenue (2010 - 2011) Analysis & Trends
Charles River Laboratories International's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $25.4 million for Q3 2011.
- In Q3 2011, Non-Current Deffered Revenue changed N/A year-over-year to $25.4 million; the TTM figure through Sep 2011 stood at $25.4 million (changed N/A YoY), while the FY2010 annual figure was $24.7 million, changed N/A from the prior year.
- Non-Current Deffered Revenue was $25.4 million for Q3 2011 at Charles River Laboratories International, up from $25.2 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $25.4 million in Q3 2011 to a low of $24.7 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 32.31 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 17.00 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Charles River Laboratories International | 9.42 Bn | 9.21 Bn | 744.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 24, 2011 | 25.45 Mn |
| Jun 25, 2011 | 25.18 Mn |
| Dec 25, 2010 | 24.66 Mn |